4王玫 关卫 倪晓辉.培哚普利对急性心肌梗塞病人左室重量的影响[J].U S Chinese Health and Hygiene J,2000,2(3):82-85.
5Massabuau P,Fourcade J,Gallinier M,et al.Ambulatory blood pressure monitoring and left ventricular hypertrophy:correlations and trial of predictive values.Arch Mal Coeur Vaiss,1992,85:1173-1179.
6Toto R,Shultz P,Raij L,et al. Efficiency and tolerabihty of losartan in hypertensive patients with renal impairment. Hypertension,1998,31(12):684-691.
7Steen A, Lise T, Peter R, et al. Renoprotective effects of angiotensin Ⅱ receptor blockade in type Ⅰ diabetic patients with diabetic nephropathy. Kidney Int, 2000,57:601-606.
8Goldberg AI,Dunlay MC,Sweet CS.Safety and tolerability of losartan potassium,an angiotensin Ⅱ receptor antagonist,compared with hydroclorothiazide, atenolol, felodipine ER, and angiotensin-coverting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol,1995,772:773.
9Oliverio MI, Coffman TM. Angotensin- Ⅱ receptor: new targets for antihypertensive therapy. Clin Cardiol, 1997,20( 1 ):3-6.
10Chan JC, Critchley JA, Lappe JT, et al. Randomised, double-blind,parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension. Hum Hypertens, 1995,9:765.
